Low prevalence of cardiac valve abnormalities in patients with autosomal dominant polycystic liver disease

Liver International

Volumn 32, Issue 4, 2012, Pages 690-692

  Gevers, Tom J G ^a   de Koning, Daan B ^a   van Dijk, Arie P ^a   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PRKCSH PROTEIN; PROTEIN; SEC63 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AORTA VALVE REGURGITATION; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; GENE SEQUENCE; HUMAN; LETTER; LIVER POLYCYSTIC DISEASE; MALE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; PREVALENCE; PULMONARY VALVE INSUFFICIENCY; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

ADULT; AGED; BASE SEQUENCE; FEMALE; GLUCOSIDASES; HEART VALVES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; MOLECULAR SEQUENCE DATA; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 84858294202     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02683.x     Document Type: Letter

References (8)

1. Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010; 52: 2223-30.
2. Gabow PA, Johnson AM, Kaehny WD, et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11: 1033-7.
3. Ecder T, Schrier RW. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-8.
4. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA. Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 907-12.
5. Timio M, Monarca C, Pede S, et al. The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10-year follow-up in a five-generation kindred. Clin Nephrol 1992; 37: 245-51.
6. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999; 341: 1-7.
7. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham heart study). Am J Cardiol 1999; 83: 897-902.
8. Qian Q, Li A, King BF, et al. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003; 37: 164-71.